Home › Type 1 Diabetes › NCT07116434

Discovery Diabetes

Discovery Diabetes: A Pilot Randomized Controlled Trial

Who can join

Ages 13 to 21 · All sexes

Inclusion Criteria:

* Adolescents (13-17 years) and young adults (aged 18-21 years),
* Diagnosed with T1D for at least one year,
* Access to a smartphone,
* A My Health at Vanderbilt (MHAV) patient portal account,
* Ability to read, speak, and understand English,
* An appointment with an NP in the VUMC Eskind Clinic within 7 months of initial contact

Exclusion Criteria:

* Diagnosis of type 2 diabetes
* Any physical, cognitive, sensory or emotional condition precluding participation in the intervention (seeing/using a phone, hearing digital stories, answering questions).

About the study

The goal of this clinical trial is to learn if the Discovery Program can help improve diabetes management in adolescents and young adults with type 1 diabetes (T1D). The main questions it aims to answer are:

Does the Discovery Program lead to better glycemic control as measured by HbA1c levels? How does participation in the Discovery Program affect diabetes distress and self-management skills? Researchers will compare participants in the Discovery Program to those receiving standard diabetes care to see if the program has a positive effect on diabetes management.

Participants will:

Engage in a 3-month intervention that includes personalized mobile health communications and clinician support.

Complete surveys and assessments at the beginning of the study, and again at 3 and 6 months.

Allow the study team to access their electronic health records for additional data on diabetes management.

What is being tested

• Discovery Program (behavioral)

Sponsor: Vanderbilt University Medical Center · Participants: 150 · Started: Nov 14, 2025

Contact the study team

• Abigail Doyle, MSHI · Phone: 615-343-6075

Official record on ClinicalTrials.gov — NCT07116434

Locations in the U.S.

Conditions

• Type 1 Diabetes

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.